References
- Casselman P, Cassiman C, Casteels I, Schauwvlieghe PP. Insights into multiple sclerosis-associated uveitis: a scoping review. Acta Ophthalmol. 2021 Sep;99(6):592–603. doi:10.1111/aos.14697.
- Shao H, Sun SL, Kaplan HJ, Sun D. Induction of autoimmune encephalomyelitis and uveitis in B6 and (B6 x SJL) mice by peptides derived from myelin/oligodendrocyte glycoprotein. J Neuroimmunol. 2002 Nov;132(1–2):117–122. doi:10.1016/S0165-5728(02)00318-1.
- Kaskow BJ, Baecher-Allan C. Effector T cells in multiple sclerosis. Cold Spring HarbPerspect Med. 2018 Apr 2;8(4):a029025. doi:10.1101/cshperspect.a029025.
- Smith JR, Stempel AJ, Bharadwaj A, Appukuttan B. Involvement of B cells in non-infectious uveitis. Clin Transl Immunology. 2016 Feb 5;5(2):e63. doi:10.1038/cti.2016.2.
- Chastain EM, Duncan DS, Rodgers JM, Miller SD. The role of antigen presenting cells in multiple sclerosis. BiochimBiophys Acta. 2011;1812:265–274.
- Hauser SL, Waubant E, Arnold DL, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. Feb 14 2008;358(7):676–688. doi:10.1056/NEJMoa0706383.
- Nussenblatt RB, Kuwabara T, de Monasterio FM, Wacker WB. S-antigen uveitis in primates. A new model for human disease. Arch Ophthalmol. 1981;99:1090–1092. doi:10.1001/archopht.1981.03930011090021.
- van Langelaar J, Rijvers L, Smolders J, van Luijn MM. B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers. Front Immunol. 2020 May 8;11:760. doi:10.3389/fimmu.2020.00760.